Business Description
Genomtec SA
ISIN : PLGNMTC00017
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.64 | |||||
Equity-to-Asset | 0.33 | |||||
Debt-to-Equity | 0.33 | |||||
Debt-to-EBITDA | -0.24 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.69 | |||||
Beneish M-Score | -4.24 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 21.3 | |||||
3-Year EPS without NRI Growth Rate | 17.7 | |||||
3-Year FCF Growth Rate | -43 | |||||
3-Year Book Growth Rate | -10 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 45.68 | |||||
9-Day RSI | 44.13 | |||||
14-Day RSI | 43.31 | |||||
6-1 Month Momentum % | -0.41 | |||||
12-1 Month Momentum % | 6.55 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.12 | |||||
Quick Ratio | 1.12 | |||||
Cash Ratio | 0.92 | |||||
Days Inventory | 24.69 | |||||
Days Sales Outstanding | 3767.26 | |||||
Days Payable | 357.1 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.5 | |||||
Shareholder Yield % | -11.21 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -845.67 | |||||
Operating Margin % | -7514.17 | |||||
Net Margin % | -7552.76 | |||||
FCF Margin % | -4743.31 | |||||
ROE % | -118.48 | |||||
ROA % | -56.42 | |||||
ROIC % | -82.54 | |||||
ROC (Joel Greenblatt) % | -473.17 | |||||
ROCE % | -69.89 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1033.33 | |||||
PB Ratio | 20.21 | |||||
EV-to-EBIT | -11.63 | |||||
EV-to-EBITDA | -14.06 | |||||
EV-to-Revenue | 858.88 | |||||
EV-to-FCF | -18.07 | |||||
Earnings Yield (Greenblatt) % | -8.6 | |||||
FCF Yield % | -5.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Genomtec SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil zł) | 0.127 | ||
EPS (TTM) (zł) | -0.76 | ||
Beta | -0.38 | ||
Volatility % | 37.45 | ||
14-Day RSI | 43.31 | ||
14-Day ATR (zł) | 0.52194 | ||
20-Day SMA (zł) | 9.525 | ||
12-1 Month Momentum % | 6.55 | ||
52-Week Range (zł) | 8.49 - 14.4 | ||
Shares Outstanding (Mil) | 12.26 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Genomtec SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Genomtec SA Stock Events
Event | Date | Price(zł) | ||
---|---|---|---|---|
No Event Data |
Genomtec SA Frequently Asked Questions
What is Genomtec SA(WAR:GMT)'s stock price today?
When is next earnings date of Genomtec SA(WAR:GMT)?
Does Genomtec SA(WAR:GMT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |